ArticleCell death & disease2018

RIPK1-dependent cell death: a novel target of the Aurora kinase inhibitor Tozasertib (VX-680).

Sofie Martens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.